UCSF home page UCSF home page About UCSF UCSF Medical Center
UCSF navigation bar
photos

Advanced Adult Hematologic Malignancies and Blood and Marrow Transplant Fellowship

The Division of Hematology and Oncology at the University of California San Francisco offers specialized training for physicians interested in adult hematologic malignancies and blood and marrow transplantation (BMT). This intensive one-year fellowship is designed to prepare physicians for academic careers in hematologic malignancies and transplantation. Our transplant program is very active, with over 190 transplants performed annually and 10 departmental faculty members capable of serving as clinical preceptors and research mentors. Active clinical and translational research programs cover a board range of topics including the development of novel conditioning regimens, hematopoiesis, leukemia, lymphoma, and multiple myeloma biology, graft vs. host disease, and immunotherapy.

Goals & Objectives:

There is no board certification in BMT. ACGME Guidelines do not apply to this fellowship-training program. Graduates of this fellowship will receive recognition of the additional hematologic malignancy and BMT training from UCSF, a FACT-accredited institution. FACT is the Foundation for the Accreditation of Cellular Therapies.

Basic Curriculum

Clinical & Research Components

The Hematologic Malignancy/BMT fellowship is a one year program and the fellow will participate in all activities of the Hematologic Malignancy/BMT group. An outline of the typical rotation schedule follows; it can be tailored slightly to fit specific career interests.

Inpatient BMT – 4 Months

Outpatient BMT – 6 Months

Research – 2 Months

Meetings

Procedural Skills

Didactic component

All fellows attend a weekly Hematology/Oncology Clinical Case Conference and a weekly Hematology/Oncology Journal Club, as well as monthly Morbidity and Mortality conference, and a monthly Research in Progress lecture. Fellows present an average of one conference per year (i.e. two lectures per year). Fellows are also expected to attend the monthly hematopathology conference and the monthly unrelated-donor selection meeting. Additional research seminars are readily available throughout the Helen Diller Family Comprehensive Cancer Center. Fellows are expected to present one talk on their research and related hematologic malignancy/BMT topic at the ‘research in progress’ lecture series and/or present their research at the annual Hematology/Oncology divisional research retreat.

Cognitive skills

Specific training and documented competency in each of the following areas:

  1. General Knowledge
    • Indications for blood and marrow transplantation
    • Documentation and reporting of patients on investigational protocols
    • Understanding the role of the Institutional Review Board and the ethical conduct in clinical trials
    • Pre-transplantation patient education
    • Identification and selection of stem cell source including use of donor registries
    • Methodology and implications of HLA typing
    • Understanding of chimerism analysis
    • Knowledge of leukapheresis procedure
    • Knowledge of blood and marrow processing and cryopreservation procedures
    • Management of ABO incompatible hematopoietic progenitor cell products
    • Administration of high-dose chemotherapy
  2. Diagnosis and management
    • Chemotherapy and radiation therapy-induced toxicities
    • Veno-occlusive disease of the liver
    • Interstitial pneumonia
    • CMV infection and disease
    • Other viral infections in immunocompromised hosts
    • Fungal disease
    • Hemorrhagic cystitis
    • Acute and chronic graft-versus-host disease
    • Late complications of blood and marrow transplantation’
  3. Management
    • Neutropenic fever
    • Thrombocytopenia and bleeding
    • Nausea and vomiting
    • Pain
    • Terminal care patients

Eligibility and Application

Candidates must be board certified in Internal Medicine and be board eligible or board certified graduates of an accredited US Hematology and/or Medical Oncology fellowship program. Due to funding restrictions, applicants must be U.S. Citizens, U.S. Permanent Residents or have a J1 Via (H1B Visas are not accepted). Applicants must be eligible for a California Medical License.

Positions Available

How to Apply

Download application and submit completed application in PDF form to Mari Collings (mari.collings@ucsf.edu). We require the following supporting documents to be submitted before your application will be considered:

Required Documents for Advanced Adult Hematologic Malignancies and Blood and Bone Marrow Transplant Fellowship

Inquiries regarding the Program can be directed to:

Mari Collings
Education Manager
UCSF – Hematology/Oncology
E-Mail: mari.collings@ucsf.edu